90 results

flags-standards
Regulation Value

Posted on 15.02.2011

The ‘New Approach’ – making standards even better

There are some who are claiming that the EU Commission’s formal objection to eleven standards raised at the end of last year shows that the ‘New Approach’ has shortcomings and that the whole system is ripe for overhaul. I would argue far from it. The New Approach is a very clever system of product regulation, […]

By Andy Vaughan Eucomed Environment Consultant

made-in
Access

Posted on 04.02.2011

Cheap trumps innovativeness… or not?

As I was commuting back to Brussels last week, a copy of The Economist laid out in front of me, my eye was immediately drawn to the title of that week’s Leader. Who wouldn’t be inclined to read on when an enticing header such as “Life should be cheap” is staring right at you. Intrigued […]

By John Wilkinson Former Chief Executive of Eucomed

comply
Business Regulation

Posted on 10.01.2011

Panel-mania? The future of an advisory interpretation

Eucomed published on 23 December 2010 its first Compliance Panel recommendation on the sponsorship of third party educational conferences by Eucomed members. The Panel, an independent body of three external opinion leading experts, was appointed to help provide guidance on the interpretation of the Eucomed Code of Ethical Business Practice as well as drive European harmonisation with […]

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance

Laboraticians
Regulation Value

Posted on 18.11.2010

There’s a good future in (DG) Research

In a time when much health industry focus is on the European Commission’s Health Directorate, DG SANCO, EU Commissioner for Research Máire Geoghegan-Quinn chose Covidien’s 20 year celebration of their Galway, Ireland, facility (congratulations to all at Covidien) to emphasise again the value of the Medical Technology industry to Europe and the huge policy and funding support that she and her Directorate, DG Research, provide to the sector.

By John Brennan Director Regulations and Industrial Policy

conference-micr
Value

Posted on 04.11.2010

Investing in education: Redefining strategy?

Any conference, congress or other important event usually involves some kind of a feedback exercise.

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance

transparent
Ethics

Posted on 01.10.2010

Adam Smith, corruption and biases

The 7th European Healthcare Fraud & Corruption Network conference took place in Brussels at the end of September and featured high level speakers and experts. The event proved to be an ideal platform for discussing a number of topics of relevance to all the stakeholders in the healthcare system. The “Conflicts of Interest” session was […]

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance

telehealth
Digital

Posted on 29.09.2010

Telemedicine – Never knowingly over sold

‘Never knowingly under sold’ is a slogan that one major UK retailer has been using more or less continuously since 1925. I have never quite understood what it means. E-heath and telemedicine have been touted as the key to disruptive change in healthcare for a very long time. I recall spending an entertaining four days […]

By John Wilkinson Former Chief Executive of Eucomed

traveler
Business Global

Posted on 20.04.2010

Musings on markets from weary traveller

Like much of the business community I have had plenty of time for thought and reading. A 24 hour trip to Milan has turned into a five day marathon. Both reading and experience have stimulated thoughts about the operation of markets. Firstly, after several hours on Thursday, I managed to secure a hotel room in […]

By John Wilkinson Former Chief Executive of Eucomed

late-payment
Global

Posted on 16.12.2009

Avoiding repeats of the ‘Greek Tragedy’

As the true depth of the Greek debt crisis unfolds it is hard to understand why the alarm bells were not ringing long ago. In our sector alone there is something in the region of €2.3 billion of unpaid bills and this has not happened overnight. We were warning of this particular symptom almost two […]

By John Wilkinson Former Chief Executive of Eucomed